{"cik":1382101,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"SUTRO BIOPHARMA, INC.","units":{"USD":[{"end":"2018-12-31","val":14724000,"accn":"0001564590-19-010253","fy":2018,"fp":"FY","form":"10-K","filed":"2019-04-01","frame":"CY2018Q4I"},{"end":"2020-12-31","val":24545000,"accn":"0000950170-22-002312","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-28","frame":"CY2020Q4I"},{"end":"2021-12-31","val":25113000,"accn":"0000950170-22-002312","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-28"},{"end":"2021-12-31","val":25113000,"accn":"0000950170-23-010976","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-30","frame":"CY2021Q4I"},{"end":"2022-12-31","val":16271000,"accn":"0000950170-23-010976","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-30"},{"end":"2022-12-31","val":16271000,"accn":"0000950170-24-035949","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-25","frame":"CY2022Q4I"},{"end":"2023-12-31","val":4061000,"accn":"0000950170-24-035949","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-25","frame":"CY2023Q4I"}]}}